13 studies found for:    hong proton | Open Studies | Exclude Unknown
Show Display Options
Rank Status Study
1 Recruiting PPI for Prevention of Post-sphincterotomy Bleeding
Conditions: Bleeding;   ERCP
Interventions: Drug: Esomeprazole;   Other: Standard care
2 Recruiting Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: FOLFIRINOX;   Drug: Losartan;   Radiation: Proton Beam Radiation
3 Recruiting Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma
Condition: Liver Cancer
Intervention: Radiation: Proton Beam Irradiation
4 Recruiting Individualized Stereotactic Body Radiotherapy of Liver Metastases
Conditions: Solid Tumor;   Liver Metastases
Intervention: Radiation: Stereotactic body radiotherapy-proton
5 Recruiting Short Course Radiation Therapy With Proton or Photon Beam Capecitabine and Hydroxychloroquine for Resectable Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Capecitabine;   Drug: Hydroxychloroquine;   Radiation: Proton or Photon Radiation Therapy
6 Recruiting PPI vs H2RA in Patients With Helicobacter Pylori-Negative Idiopathic Bleeding Ulcers
Condition: Peptic Ulcer
Interventions: Drug: Lansoprazole;   Drug: Famotidine
7 Recruiting H2RA VS PPI for the Prevention of Ulcer Bleeding Associated With Low-dose Aspirin in Patients With Very High Ulcer Risk
Condition: Peptic Ulcer Bleeding
Interventions: Drug: Rabeprazole;   Drug: Famotidine
8 Recruiting BRAVO Study for Functional Dyspepsia
Conditions: Dyspepsia;   Gastroesophageal Reflux
Interventions: Drug: Esomeprazole 20mg;   Other: Placebo
9 Recruiting High Dose Amoxicillin Versus Tetracycline as Second-line Treatment of Resistant Helicobacter Pylori Infection
Condition: Helicobacter Pylori Treatment Failure
Interventions: Drug: Lansoprazole;   Drug: Bismuth Potassium Citrate;   Drug: Metronidazole;   Drug: Amoxicillin;   Drug: Tetracycline
10 Recruiting Amoxicillin/Metronidazole Based Quadruple Therapy for Helicobacter Pylori Eradication
Conditions: Dyspepsia;   Peptic Ulcer
Interventions: Drug: Lansoprazole;   Drug: Bismuth Potassium Citrate;   Drug: Amoxicillin;   Drug: Metronidazole;   Drug: Clarithromycin
11 Recruiting FOLFIRINOX + RT for Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: FOLFIRINOX;   Drug: Capecitabine;   Radiation: Short Course Radiation;   Procedure: Surgery
12 Recruiting Early Selective Transarterial Embolization (TAE) to Severely Bleeding Peptic Ulcers After Their Initial Endoscopic Hemostasis
Conditions: Bleeding;   Peptic Ulcer;   Arterial Embolization
Interventions: Procedure: TAE;   Procedure: No TAE
13 Not yet recruiting A Pilot Study of Neoadjuvant Therapy With Gemcitabine and Cisplatin in Patients With Resectable or Unresectable Intrahepatic Cholangiocarcinoma
Conditions: Unresectable Intrahepatic Cholangiocarcinoma;   Resectable Intrahepatic Cholangiocarcinoma
Interventions: Drug: Gemcitabine;   Drug: Cisplatin;   Procedure: Surgery;   Radiation: Radiation

Indicates status has not been verified in more than two years